C07K 14/76
Albumins
C07K14/76 (Albumins) appears on 1,015 US grants and 1,401 published applications in this corpus.
Search patents in C07K- Granted patents
- 1,015
- Published applications
- 1,401
- Assignees
- 724
- Inventors
- 2,732
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 5 | 0 |
| 1978 | 5 | 0 |
| 1979 | 5 | 0 |
| 1980 | 4 | 0 |
| 1981 | 4 | 0 |
| 1982 | 3 | 0 |
| 1983 | 2 | 0 |
| 1984 | 3 | 0 |
| 1985 | 3 | 0 |
| 1986 | 2 | 0 |
| 1987 | 4 | 0 |
| 1988 | 4 | 0 |
| 1989 | 6 | 0 |
| 1990 | 10 | 0 |
| 1991 | 7 | 0 |
| 1992 | 11 | 0 |
| 1993 | 12 | 0 |
| 1994 | 20 | 0 |
| 1995 | 9 | 0 |
| 1996 | 13 | 0 |
| 1997 | 30 | 0 |
| 1998 | 46 | 0 |
| 1999 | 23 | 0 |
| 2000 | 20 | 0 |
| 2001 | 18 | 2 |
| 2002 | 20 | 32 |
| 2003 | 23 | 43 |
| 2004 | 12 | 23 |
| 2005 | 14 | 35 |
| 2006 | 21 | 43 |
| 2007 | 18 | 31 |
| 2008 | 9 | 40 |
| 2009 | 21 | 37 |
| 2010 | 12 | 39 |
| 2011 | 22 | 36 |
| 2012 | 19 | 44 |
| 2013 | 28 | 51 |
| 2014 | 27 | 72 |
| 2015 | 44 | 61 |
| 2016 | 39 | 95 |
| 2017 | 44 | 64 |
| 2018 | 32 | 76 |
| 2019 | 40 | 75 |
| 2020 | 51 | 61 |
| 2021 | 62 | 78 |
| 2022 | 36 | 75 |
| 2023 | 42 | 87 |
| 2024 | 35 | 86 |
| 2025 | 52 | 53 |
| 2026 | 21 | 62 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Ulinastatin polypeptides8 Sep 2026US 12,729,233 B2DiaMedica USA Inc.
- Treatment using cytokine encoding RNA18 Aug 2026US 12,708,643 B2BioNTech SE
- Albumin-proaerolysin prodrugs28 Jul 2026US 12,691,158 B2The Johns Hopkins University
- Extracellular vesicles and compositions thereof14 Jul 2026US 12,678,465 B2Exo Biologics SA
- Separation apparatus and method26 May 2026US 12,636,615 B2The Penn State Research Foundation
- Extracellular Vesicles and Compositions Thereof1 Oct 2026US 2026/0294977 A1Exo Biologics SA
- Modified rna with decreased immunostimulatory properties24 Sep 2026US 2026/0284227 A1CureVac AG
- Cd40l-specific tn3-derived scaffolds for the treatment and prevention of sjogren's syndrome24 Sep 2026US 2026/0285994 A1Viela Bio, Inc.
- Nucleic acid constructs and methods of use17 Sep 2026US 2026/0273105 A1Intellia Therapeutics, Inc.
- Fusion proteins comprising truncated forms of iga protease and uses thereof17 Sep 2026US 2026/0275321 A1Peking University First Hospital
Most cited
By later US patents
- Transgenic bovine266US 5,741,957 APharming B.V. · 1998
- Homologous recombination in mammalian cells248US 5,721,367 APharming B.V. · 1998
- Homologous recombination in mammalian cells236US 5,612,205 AGenPharm International, Inc. · 1997
- Fusion polypeptides comprising human serum albumin, nucleic acids encoding same, and recombinant expression thereof208US 5,876,969 A1999
- Albumin fusion proteins comprising GLP-1 polypeptides198US 7,141,547 B2Human Genome Sciences, Inc. · 2006